GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma

BACKGROUND: The ETS transcription factor GABPA has long been thought of as an oncogenic factor and recently suggested as a target for cancer therapy due to its critical effect on telomerase activation, but the role of GABPA in clear cell renal cell carcinoma (ccRCC) is unclear. In addition, ccRCC is...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Zhiqing, Zhang, Ning, Yuan, Xiaotian, Xing, Xiangling, Li, Xiaofeng, Qin, Xin, Liu, Zhengfang, Neo, Shiyong, Liu, Cheng, Kong, Feng, Björkholm, Magnus, Fan, Yidong, Xu, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097325/
https://www.ncbi.nlm.nih.gov/pubmed/35549739
http://dx.doi.org/10.1186/s13046-022-02382-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097325/
https://www.ncbi.nlm.nih.gov/pubmed/35549739
http://dx.doi.org/10.1186/s13046-022-02382-6

Ejemplares similares